Spectralytics Adds To $22M IP Verdict Against Cordis

Law360, San Diego (December 01, 2011, 7:07 PM ET) -- A Minnesota federal court on Wednesday ordered Cordis Corp. and stent manufacturer Norman Noble Inc. to pay $500,000 in enhanced damages on top of a $22 million verdict against them for willfully infringing Spectralytics Inc.’s patent covering a stent-cutting machine.

Spectralytics asked the court to increase the damages amount up to three times and sought more than $4 million in attorneys’ fees, but U.S. District Judge Patrick Schiltz declined to award any attorneys’ fees and determined that while the $500,000 amount was small compared to Johnson...
To view the full article, register now.